| Description |
| Product Type |
Product Size |
| Injection |
1'S |
| Product Company |
| Rotex Pharma |
Aprepitant 125mg,80mg |
| Product Type |
Product Size |
| Tablet |
30'S |
| Product Company |
| Wilson Pharmaceuticals |
Amlodipine besylate 10mg |
| Product Type |
Product Size |
Product Company |
| Injection |
1'S |
Himmel Pharma |
|
| Product Type |
Product Size |
Product Company |
| Injection |
1'S |
Sandoz |
|
| Product Type |
Product Size |
| Tablet |
30'S |
| Product Company |
| Sanofi |
Furosemide and amiloride 5mg |
| Product Type |
Product Size |
| Injection |
1'S |
| Product Company |
| Pfizer
|
Carboplatin 150mg/15ml
|
| Content | Aprepitant is a medication used to manage and treat chemotherapy- induced nausea and vomiting and postoperative nausea and vomiting. | Amlodipine is used alone or in combination with other medications to treat high blood pressure in adults and children 6 years and older. It is also used to treat certain types of angina (chest pain) and coronary artery disease (narrowing of the blood vessels that supply blood to the heart) | Docetaxel is a taxoid antineoplastic agent used in the treatment of various cancers, such as locally advanced or metastatic breast cancer, metastatic prostate cancer, gastric adenocarcinoma, and head and neck cancer. | Docetaxel is a chemotherapy medication used to treat a number of types of cancer.This includes breast cancer , head and neck cancer , stomach cancer , Prostate cancer ,and non small cell lung cancer. It may be used by itself or along with other chemothearpy medication. | A combination of Furosemide and Amiloride is a diuretic which reduces the potassium loss of furosemide alone while avoiding the possible gastro-intestinal disturbances of potassium supplements.
| Carboplatin is a platinum-containing chemotherapy medicine, which belongs to the alkylating agents group of medicines. It is used to treat various cancers. It prevents growth of cancerous cells by damaging their DNA that aids in its proliferation.
|
Reviews
There are no reviews yet.